Alteration of myo-inositol monophosphatase in Alzheimer's disease brains

Neurosci Lett. 1998 Apr 10;245(3):159-62. doi: 10.1016/s0304-3940(98)00209-2.

Abstract

myo-Inositol monophosphatase (E.C.3.1.3.25) catalyzes the hydrolysis of myo-inositol 1-phosphate in the presence of Mg2+ at a physiologic pH to form free myo-inositol, maintaining a supply that represents the precursor for inositol phospholipid second messenger signaling systems. In the present study the activity and protein level of myo-inositol monophosphatase were investigated in samples from normal human and Alzheimer's disease (AD) postmortem brains. The separation profile on Sephadex G-100 gel filtration chromatography revealed one major form of myo-inositol monophosphatase in crude extracts from both normal human and AD brains. In AD brains myo-inositol monophosphatase activity and its protein level were significantly higher than in control brains. The activity of myo-inositol monophosphatase per enzyme molecule was similar in control and AD brains. These results suggest that myo-inositol monophosphatase is upregulated in AD, probably reflecting compensatory mechanisms concerned with phospholipid metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / enzymology*
  • Animals
  • Brain / enzymology*
  • Humans
  • Phospholipids / metabolism
  • Phosphoric Monoester Hydrolases / analysis
  • Phosphoric Monoester Hydrolases / metabolism*
  • Rats
  • Rats, Wistar

Substances

  • Phospholipids
  • Phosphoric Monoester Hydrolases
  • myo-inositol-1 (or 4)-monophosphatase